Adverse Events at 1 Month Following Medication Initiation for Opioid Use Disorder Among Adolescents and Young Adults.
Mishka TerplanKevin E O'GradyLaura B MonicoRobert P SchwartzJan GryczynskiMarc J FishmanShannon Gwin MitchellPublished in: Substance use & addiction journal (2024)
Excluding injection site reactions, there were no significant differences in the likelihood of reporting an AE 1 month after receiving LAI-NTX, buprenorphine, and no medications. LAI-naltrexone should be among the medications offered for the treatment of OUD in youth.